China’s new drug approvals take market scale beyond US$13 billion as innovation picks up

SCMP | Nov. 17, 2024, 7 a.m. | Original
China has already approved nearly thrice the number of innovative drugs than in the 13th five-year plan, Shanghai forum hears.
Operation Santa Claus: Hong Kong group to train ‘well-being practitioners’ to help pupils Pope Francis calls for genocide investigation into Israel’s attacks in Gaza